Stockscreener 앱 받기
71.14
3.41%
-2.51
Tarsus Pharmaceuticals Inc 주식(TARS)의 최신 뉴스
Relative Strength Alert For Tarsus Pharmaceuticals - Nasdaq
Does Tarsus Pharmaceuticals (NASDAQ:TARS) Have A Healthy Balance Sheet? - simplywall.st
While shareholders of Tarsus Pharmaceuticals (NASDAQ:TARS) are in the black over 3 years, those who bought a week ago aren't so fortunate - Yahoo Finance
Understanding Momentum Shifts in (TARS) - Stock Traders Daily
BMRN or TARS: Which Is the Better Value Stock Right Now? - Yahoo Finance
Aug PostEarnings: Why Tarsus Pharmaceuticals Inc. stock could rally in 20252025 Bull vs Bear & AI Based Trade Execution Alerts - Bộ Nội Vụ
Tarsus Pharmaceuticals, Inc. Publishes Corporate Presentation on Eye Care Innovations - TradingView — Track All Markets
What analyst consensus says on Tarsus Pharmaceuticals Inc. stockStop Loss & Smart Allocation Stock Tips - Улправда
Why Tarsus Pharmaceuticals Inc. stock is trending among retail tradersPortfolio Value Report & Real-Time Stock Entry Alerts - Улправда
Growth Recap: Why Tarsus Pharmaceuticals Inc. stock is trending among retail tradersMarket Activity Summary & Free Long-Term Investment Growth Plans - Улправда
Will Tarsus Pharmaceuticals Inc. stock outperform tech sector in 2025Portfolio Gains Summary & Free Real-Time Volume Trigger Notifications - Улправда
Tarsus Pharmaceuticals (NASDAQ:TARS) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway - 富途牛牛
Insider Sell Alert: Dianne Whitfield Sells 15,565 Shares of Tarsus Pharmaceuticals Inc (TARS) - GuruFocus
Avoiding Lag: Real-Time Signals in (TARS) Movement - Stock Traders Daily
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) CEO Bobak Azamian Sells 6,000 Shares - MarketBeat
Tarsus Pharmaceuticals Insider Sold Shares Worth $495,089, According to a Recent SEC Filing - MarketScreener
Tarsus Pharmaceuticals (TARS) Investor Outlook: Strong Buy Ratings and Promising Revenue Growth in Biotech - DirectorsTalk Interviews
Will Tarsus Pharmaceuticals Inc. stock split attract more investorsDividend Cut Warnings & Low Risk Investment Plans - bollywoodhelpline.com
Tarsus to Participate at the Bank of America 2023 Healthcare Conference - 富途牛牛
240,020 Shares in Tarsus Pharmaceuticals, Inc. $TARS Purchased by Capricorn Fund Managers Ltd - MarketBeat
Tarsus Pharmaceuticals Earnings Notes - Trefis
Market Sentiment Around Loss-Making Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - simplywall.st
Will Tarsus Pharmaceuticals Inc. stock see PE expansionTake Profit Strategies & Free Hedging Tactics for Volatile Markets - Bollywood Helpline
Tarsus Pharmaceuticals (TARS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Technical Reactions to TARS Trends in Macro Strategies - Stock Traders Daily
Why Tarsus Pharmaceuticals Inc. stock could rally in 2025July 2025 Opening Moves & Weekly Breakout Watchlists - Улправда
Can Tarsus Pharmaceuticals Inc. stock double in next 5 yearsJuly 2025 Retail & AI Enhanced Trading Signals - Улправда
Can Tarsus Pharmaceuticals Inc. stock hit record highs againJuly 2025 Trade Ideas & AI Driven Price Predictions - DonanımHaber
Why analysts upgrade Tarsus Pharmaceuticals Inc. stock2025 Technical Overview & Fast Gaining Stock Reports - Улправда
Insider Sell: Dianne Whitfield Sells 7,397 Shares of Tarsus Phar - GuruFocus
Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Dianne Whitfield Sells 7,397 Shares - MarketBeat
Tarsus Pharmaceuticals Insider Sold Shares Worth $592,500, According to a Recent SEC Filing - marketscreener.com
Tarsus Pharmaceuticals (TARS) COO discloses stock gifts and 79,183-share stake - Stock Titan
Assenagon Asset Management S.A. Has $74.17 Million Stock Holdings in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Officer Whitfield Files To Sell 7,397 Of Tarsus Pharmaceuticals Inc [TARS] - TradingView — Track All Markets
Squarepoint Ops LLC Boosts Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
TFG Asset Management GP Ltd Grows Stake in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Trading the Move, Not the Narrative: (TARS) Edition - Stock Traders Daily
Tarsus Pharmaceuticals (NASDAQ:TARS) Upgraded at Barclays - MarketBeat
Tarsus Pharmaceuticals chief medical officer talks AI in eye care - Healthcare Brew
Barclays Initiates Coverage on Tarsus Pharmaceuticals (TARS) wit - GuruFocus
Jump Financial LLC Purchases 188,317 Shares of Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Norges Bank Acquires Shares of 471,354 Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) Sets New 12-Month HighHere's What Happened - MarketBeat
Tarsus Pharmaceuticals stock hits all-time high at 83.67 USD - Investing.com
Tarsus Pharmaceuticals stock hits all-time high at 83.67 USD By Investing.com - Investing.com Australia
Tarsus Pharmaceuticals Leads Six-Month Stock Performance with 85.5% Return - MarketsMojo
Quantbot Technologies LP Purchases 24,319 Shares of Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Can Tarsus Pharmaceuticals Stock Still Offer Value After Its 48% 2025 Rally? - Yahoo Finance
Tarsus Pharmaceuticals (TARS): Revisiting Valuation After a Strong Multi‑Year Share Price Run - Sahm
Quadrature Capital Ltd Invests $588,000 in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
(TARS) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
4.73%
0.92%
자본화:
|
볼륨(24시간):